Sciences de la Vie

Conformément à la vision du Gouvernement de Maurice à l’effet d’élargir son espace économique, l’Economic Development Board (EDB) a identifié, dans le secteur médical, les activités à haute valeur ajoutée de la biotechnologie rouge (biotechnologie de la santé) comme domaine à fort potentiel.

L’Ile Maurice dispose déjà d’un secteur de recherche clinique naissant à fort potentiel d’expansion. L’introduction de la Loi sur les Essais Cliniques, en 2011, a mis ce secteur en lumière. Le domaine de la biotechnologie médicale compte un chiffre d’affaires dépassant les MUR 2.3 milliards ; il y a couramment 4 Organismes de Recherche sous Contrat (ORC) opérant sur l’île aux fins d’essais cliniques pour diverses pathologies telles l’hépatite, le diabète, le VIH etc.

L’Ile Maurice présente une population multi-ethnique indemne d’accoutumance pharmacologique. Tenant compte des maladies infectieuses et de civilisation prévalant maintenant dans les pays de la région, tel le diabète, les maladies cardiovasculaires, le cancer, l’hypertension, l’Ile Maurice présente un potentiel pour la conduite d’essais cliniques.

+ 1000






  • Setting up of a Clinical Research Organization (CRO) /Clinical Research

    There is a rising incidence of cancer, cardiovascular diseases, diabetes and hypertension amongst others in Mauritius. In this regard, the country provides an ideal platform for clinical research.
    Clinical trials (Phase I– Phase IV) are performed in partnership with specialists in the field (gynecologists, diabetologists, cardiologists, dermatologists, etc.). As at date, more than 30 clinical trials have been run on the island.

    Pre-clinical Research

    Proclamation of the Animal Welfare (Experiment on Animals) Act 2017 has opened up the full chain of pharmaceutical research and will enable companies involved in breeding to expand into pre-clinical research in collaboration with biotech companies. The Mauritian cynomolgus macaque, because of its insular habitat exhibits remarkable peculiarities is highly desired by researchers. These primates are known to be virus-free and genetically homogenous, which make them also very effective in pre-clinical research.

    Research Laboratories & Nutraceuticals

    Mauritius has a rich and diverse flora, with more than 670 species of flowering plants of which 315 are endemic. Furthermore, the East African region is already considered as a biodiversity hotspot. This represents a tremendous opportunity for the development of a nutraceutical industry. Pharmaceutical industry per se has failed to grow substantially due to massive R&D investment and non-competitiveness for generic medicine. Nutraceuticals which is basically food additive and wellbeing materials (moringa, Betel, Rodrigues lemon leaves, etc.) can open new avenues of research and product development.

    • Accelerated depreciation of 50% in respect of capital expenditure incurred on R&D, that is the investment cost is fully amortised in 2 years
    • A double deduction in respect of qualifying expenditure on R&D directly related to the entity’s trade or business and provided the R&D is carried out in Mauritius.
    • Exemption of registration duty on acquisition of immovable property in the lifesciences sector
    • VAT exemption on construction of medical R&D centers
    • VAT exemption on plants and equipment
    • 8 years tax holiday for companies involved in manufacture of nutraceuticals and pharmaceutical products

Chat with us

Talk to us